Published in Clin J Am Soc Nephrol on June 18, 2009
Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60
Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study. BMJ (2015) 3.34
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2010) 2.18
Mortality and cardiovascular disease among older live kidney donors. Am J Transplant (2014) 2.16
A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data. Pharmacoepidemiol Drug Saf (2012) 2.11
A systematic review of validated methods for identifying heart failure using administrative data. Pharmacoepidemiol Drug Saf (2012) 1.86
Race, Relationship and Renal Diagnoses After Living Kidney Donation. Transplantation (2015) 1.45
Validation of CKD and related conditions in existing data sets: A systematic review. Am J Kidney Dis (2010) 1.26
Increasing utilization of pediatric epilepsy surgery in the United States between 1997 and 2009. Epilepsia (2015) 1.22
Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation (2014) 1.22
Renal function and healthcare costs in patients with polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.10
Potential therapeutic competition in community-living older adults in the U.S.: use of medications that may adversely affect a coexisting condition. PLoS One (2014) 1.08
Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review. PLoS One (2015) 1.04
Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with medicare claims. Circ Cardiovasc Qual Outcomes (2014) 1.03
Electronic health records: a new tool to combat chronic kidney disease? Clin Nephrol (2013) 1.03
Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation (2012) 0.99
Big data in organ transplantation: registries and administrative claims. Am J Transplant (2014) 0.99
The impact of kidney transplantation on heart failure risk varies with candidate body mass index. Am Heart J (2009) 0.86
Better understanding live donor risk through big data. Clin J Am Soc Nephrol (2013) 0.81
Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis. J Nephrol (2012) 0.80
Reliability of Medicare claim forms for outcome studies in kidney transplant recipients: epidemiology in clinical outcome trials. Clin J Am Soc Nephrol (2009) 0.80
Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation. Transplantation (2016) 0.76
Patterns of Care and Outcomes in Cardiovascular Disease After Kidney Transplantation in the United States. Transplant Direct (2017) 0.75
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 7.75
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57
Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels. JAMA (2000) 6.10
Cancer after kidney transplantation in the United States. Am J Transplant (2004) 5.08
Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care (2004) 5.03
Identifying persons with diabetes using Medicare claims data. Am J Med Qual (2000) 5.02
Diabetes mellitus after kidney transplantation in the United States. Am J Transplant (2003) 4.39
Estimating the burden of disease. Comparing administrative data and self-reports. Med Care (1997) 3.27
Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol (2004) 1.93
Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States. Am J Kidney Dis (2004) 1.91
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments. Transplantation (2000) 1.72
Cardiovascular disease after renal transplantation. J Am Soc Nephrol (1996) 1.58
Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis (2004) 1.45
Evaluation of ICD-9 codes for syndromic surveillance in the electronic surveillance system for the early notification of community-based epidemics. Mil Med (2007) 1.34
Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol (2006) 1.29
Depressive disorder in renal transplantation: an analysis of Medicare claims. Am J Kidney Dis (2008) 1.22
Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol (2005) 1.11
De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications. Am J Kidney Dis (2005) 1.09
Quality of care in for-profit and not-for-profit health plans enrolling Medicare beneficiaries. Am J Med (2005) 1.09
Novel methods for tracking long-term maintenance immunosuppression regimens. Clin J Am Soc Nephrol (2007) 1.04
Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure. Clin J Am Soc Nephrol (2008) 1.02
Hospitalized congestive heart failure after renal transplantation in the United States. Ann Epidemiol (2002) 0.98
Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus. J Am Soc Nephrol (2004) 0.90
Peripheral arterial disease and renal transplantation. J Am Soc Nephrol (2006) 0.89
International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43
Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog (2007) 8.01
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
Survival advantages of obesity in dialysis patients. Am J Clin Nutr (2005) 3.75
Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57
Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research. Transplantation (2008) 3.43
Early mobilization of patients hospitalized with community-acquired pneumonia. Chest (2003) 2.85
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant (2005) 2.76
Rate of kidney function decline associates with mortality. J Am Soc Nephrol (2010) 2.76
Quality of care in patients with chronic hepatitis C virus infection: a cohort study. Ann Intern Med (2010) 2.44
Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission. Liver Transpl (2009) 2.38
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation (2009) 2.33
Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant (2003) 2.22
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant (2005) 2.19
Cost-utility analysis of sodium polystyrene sulfonate vs. potential alternatives for chronic hyperkalemia. Clin Nephrol (2014) 1.98
Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol (2004) 1.93
Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. J Am Soc Nephrol (2011) 1.90
Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis (2002) 1.82
The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation. Liver Transpl (2011) 1.79
Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol (2003) 1.77
Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation (2009) 1.75
Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing. Virology (2012) 1.75
Living donation decision making: recipients' concerns and educational needs. Prog Transplant (2006) 1.73
Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant (2005) 1.73
Association of oral sodium phosphate purgative use with acute kidney injury. J Am Soc Nephrol (2007) 1.72
Health insurance considerations for adolescent transplant recipients as they transition to adulthood. Pediatr Transplant (2007) 1.68
Transplantation of A2 kidneys into B and O recipients leads to reduction in waiting time: USRDS experience. Transplantation (2010) 1.60
Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes. Transplantation (2010) 1.57
Assessment of racial disparities in chronic kidney disease stage 3 and 4 care in the department of defense health system. Clin J Am Soc Nephrol (2008) 1.56
Arteriovenous fistulas among incident hemodialysis patients in Department of Defense and Veterans Affairs facilities. J Am Soc Nephrol (2010) 1.56
Incidence, predictors and associated outcomes of rhabdomyolysis after kidney transplantation. Nephrol Dial Transplant (2009) 1.52
Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation. Transplantation (2004) 1.51
Race, Relationship and Renal Diagnoses After Living Kidney Donation. Transplantation (2015) 1.45
Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation. J Am Soc Nephrol (2008) 1.45
Transplant certification and quality assessment: time to take the front line? Prog Transplant (2013) 1.43
Cost Implications of New National Allocation Policy for Deceased Donor Kidneys in the United States. Transplantation (2016) 1.42
Response to 'viral hepatitis guidelines for transplant recipients'. Am J Transplant (2005) 1.39
US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2016) 1.37
BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol (2007) 1.36
Dementia as a predictor of mortality in dialysis patients. Clin J Am Soc Nephrol (2006) 1.36
Damned if you do, damned if you don't: potassium binding resins in hyperkalemia. Clin J Am Soc Nephrol (2010) 1.35
Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis (2003) 1.34
Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant (2004) 1.33
The interplay of socioeconomic status, distance to center, and interdonor service area travel on kidney transplant access and outcomes. Clin J Am Soc Nephrol (2010) 1.32
Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Kidney Int (2003) 1.32
An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation (2009) 1.31
Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis. Transplantation (2006) 1.29
Resource utilization in patients hospitalized with heart failure: insights from a contemporary national hospital database. Am Heart J (2008) 1.27
Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation (2008) 1.27
Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int (2002) 1.27
BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol (2008) 1.25
Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation (2014) 1.22
The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation (2003) 1.22
Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol (2008) 1.21
Association of incident gout and mortality in dialysis patients. J Am Soc Nephrol (2008) 1.20
Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis (2008) 1.20
HIV-associated nephropathy and end-stage renal disease in children in the United States. Pediatr Nephrol (2004) 1.19
Effect of donor factors on early graft survival in adult cadaveric renal transplantation. Am J Transplant (2002) 1.19
Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol (2010) 1.17
Serum sickness after treatment with rabbit antithymocyte globulin in kidney transplant recipients with previous rabbit exposure. Am J Kidney Dis (2009) 1.15
Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis (2007) 1.14
The implications of acute rejection for allograft survival in contemporary U.S. kidney transplantation. Transplantation (2012) 1.14
Epidemiology of dialysis patients and heart failure patients. Semin Nephrol (2006) 1.13
Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure. Transplantation (2006) 1.13
Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. J Am Soc Nephrol (2006) 1.13
Incidence of sodium polystyrene sulfonate-associated colonic necrosis. Am J Med (2013) 1.11
Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol (2005) 1.11
Renal function and healthcare costs in patients with polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.10
Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient. Arch Ophthalmol (2008) 1.09
De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications. Am J Kidney Dis (2005) 1.09
Factors associated with improved short term survival in obese end stage renal disease patients. Ann Epidemiol (2003) 1.09
Association of prescription of oral sodium polystyrene sulfonate with sorbitol in an inpatient setting with colonic necrosis: a retrospective cohort study. Am J Kidney Dis (2012) 1.08
Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation. Transplantation (2004) 1.07
The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients. Am J Transplant (2004) 1.07
Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation (2007) 1.06
Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. Transplantation (2014) 1.04